Ogden Christopher

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$12,403.26

Insider Activity of Ogden Christopher

According to the SEC Form 4 filings, Ogden Christopher, being in a position of

  1. Chief Financial Officer at CytomX Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 6945 shares for $11,382,
    over all time since 2023-03-16, has bought 0 shares, and sold 7461 share for $12,403.

The largest sale of all time was on 2024-03-19 and amounted to 2971 share of CytomX Therapeutics, Inc. for $6,196.

Biography of Ogden Christopher

No biography is available at this moment.

2024-08-20SaleCytomX Therapeutics, Inc.
CTMX
Chief Financial Officer
1,984
0.0025%
$1.23$2,439-4.03%
2024-03-19SaleCytomX Therapeutics, Inc.
CTMX
SVP, Finance and Accounting
2,971
0.0042%
$2.09$6,196-28.9%
2023-12-20SaleCytomX Therapeutics, Inc.
CTMX
SVP, Finance and Accounting
1,990
0.0031%
$1.38$2,747+19.74%
2023-03-16SaleCytomX Therapeutics, Inc.
CTMX
SVP, Finance and Accounting
516
0.0008%
$1.98$1,021-20.62%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.